CLINICAL_TRIALS
trial_result
· 2013-05-30
Clinical Trial Update: Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria [Phase 3]
Summary
A Phase 3 clinical trial update for eculizumab in paroxysmal nocturnal hemoglobinuria shows the study status as completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Leukemia | Phase 3 | Status: COMPLETED